1. Drug-regulated CD33-targeted CAR T cells control AML using clinically optimized rapamycin dosing
- Author
-
Appelbaum, Jacob, primary, Price, April E., additional, Oda, Kaori, additional, Zhang, Joy, additional, Leung, Wai-Hang, additional, Tampella, Giacomo, additional, Xia, Dong, additional, So, Pauline P.L., additional, Hilton, Sarah K., additional, Evandy, Claudya, additional, Sarkar, Semanti, additional, Martin, Unja, additional, Krostag, Anne-Rachel, additional, Leonardi, Marissa, additional, Zak, Daniel E., additional, Logan, Rachael, additional, Lewis, Paula, additional, Franke-Welch, Secil, additional, Ngwenyama, Njabulo, additional, Fitzgerald, Michael, additional, Tulberg, Niklas, additional, Rawlings-Rhea, Stephanie, additional, Gardner, Rebecca A., additional, Jones, Kyle, additional, Sanabria, Angelica, additional, Crago, William, additional, Timmer, John, additional, Hollands, Andrew, additional, Eckelman, Brendan, additional, Bilic, Sanela, additional, Woodworth, Jim, additional, Lamble, Adam, additional, Gregory, Philip D., additional, Jarjour, Jordan, additional, Pogson, Mark, additional, Gustafson, Joshua A., additional, Astrakhan, Alexander, additional, and Jensen, Michael C., additional
- Published
- 2024
- Full Text
- View/download PDF